ARCHIVES

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

This article is from The Cancer Letter archive.

Vol. 05 No. 29 | July 20, 1979

Download PDF Visit The Full Archive

Related Articles

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

Senate Confirms McClellan For FDA

October 25, 2002

NCI Proposed 1980 Budget Increases R01 Grants By $50 Million Over ’79; Total – $1.055 Billion

June 9, 1978

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007